Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Approvals
Moberg Pharma AB (Formerly known as Moberg Derma)'s Fungal Nail Product Approved In China 1/27/2015 10:49:52 AM
FDA Backs Teva Pharmaceutical Industries Limited (TEVA)'s Generic Nexium in Blow to AstraZeneca PLC (AZN), Ranbaxy Laboratories (RANBAXY.BO) 1/27/2015 6:59:15 AM
Novo Nordisk A/S (NVO) Receives FDA Approval For Norditropin® Flexpro® 30 Mg/3.0 Ml For Patients With Growth Hormone Disorders 1/27/2015 7:31:00 AM
Symplmed Announces FDA Approval of Prestalia® for Treatment of Hypertension 1/26/2015 7:20:15 AM
FDA Says Yes to Rockwell Medical (RMTI)'s Iron Replacement Drug 1/26/2015 6:40:00 AM
Shire (SHPGY)'s $5.2 Billion Bet Pays Off as NPS Pharmaceuticals, Inc. (NPSP)'s Natpara Wins Approval 1/26/2015 6:16:44 AM
FDA Approves Rockwell Medical (RMTI)l's Triferic™ For Iron Replacement And Maintenance Of Hemoglobin In Hemodialysis Patient 1/26/2015 6:44:04 AM
The National Meningitis Association (NMA) Applauds FDA Approval Of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 1/26/2015 10:06:22 AM
Shire Comments On Press Release From FDA Regarding NPS Pharmaceuticals, Inc. (NPSP) Approval Of NATPARA® (Parathyroid Hormone) 1/26/2015 9:07:22 AM
Novartis AG (NVS) Bexsero® Vaccine Approved By FDA For The Prevention Of Meningitis B, The Leading Cause Of Bacterial Meningitis In The US 1/26/2015 7:45:42 AM
NPS Pharmaceuticals, Inc. (NPSP) Release: FDA Approves Natpara┬« (Parathyroid Hormone) For Injection As An Adjunct To Calcium And Vitamin D To Control Hypocalcemia In Patients With Hypoparathyroidism 1/26/2015 6:21:00 AM
FDA Approves Novartis AG (NVS)'s Cosentyx for Painful Skin Disease 1/21/2015 4:17:56 PM
Incyte Corporation (INCY) Earns $25 Million Milestone As Jakavi® (ruxolitinib) Recommended For Approval In Europe For Polycythemia Vera 1/23/2015 6:26:50 AM
Marrone Bio Innovations, Inc' REGALIA® MAXX Biofungicide Approved For New Uses In Canada 1/22/2015 8:33:12 AM
Novartis AG (NVS) Announces FDA Approval For First IL-17A Antagonist Cosentyx™ (Secukinumab) For Moderate-To-Severe Plaque Psoriasis Patients 1/21/2015 4:19:00 PM
1234567
//-->